We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
No events to show.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis - ACCESS Newswire
Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis ACCESS Newswire
Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis
Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements - ACCESS Newswire
Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements ACCESS Newswire
Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025 - Yahoo Finance
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025 Yahoo Finance
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 03. 31. | After market close (AMC) | — | — | — | — | — | Scheduled |
No research actions to show.
Price data
No holdings data to show.